Uncategorized
-
PERMASTEELISA GARTNER MIDDLE EAST SECURES FAÇADE CONTRACT FOR FRANCK MULLER AETERNITAS TOWER
Permasteelisa Gartner Middle East, part of leading international façade specialist Permasteelisa Group, has been appointed by London Gate to design,…
Read More » -
CUCINA WELCOMES BACK ITS ITALIAN #DREAMTEAM WITH A SUMMER FULL OF FLAVOUR AND FAMILY FUN
Keep cool at Cucina: The Palm’s favourite neighbourhood Italian unveils new summer offerings, Gelateria classes, and the return of the…
Read More » -
HONOR Launches the New HONOR Magic V5 in China
HONOR sets yet another industry benchmark for thin and lightweight inward-folding smartphone design Global AI device ecosystem company HONOR today…
Read More » -
Led by HRH Prince Sultan bin Salman… Preparations Begin for the General Aviation Exhibition “Sand & Fun 2025”
His Royal Highness Prince Sultan bin Salman bin Abdulaziz, Founder and Chairman of the Saudi Aviation Club, chaired an official…
Read More » -
Discover the World’s Most Liveable Cities with IHG Hotels & Resorts
The Economist Intelligence Unit (EIU) has unveiled its 2025 Global Liveability Index, celebrating the cities that define exceptional quality of…
Read More » -
Teammates.ai Launches Sara, the AI Interviewer — Hire in a Few Days and Cut Screening Costs by 85%
AI Teammate that interviews for any role, in 50+ languages, surfaces 5X more high-performers, and delights 92% of candidates. Teammates.ai,…
Read More » -
Whitewill Expands Operations to Oman, Strengthening Regional Real Estate Presence
Whitewill, the international luxury real estate agency, has officially expanded its footprint into Oman, marking a strategic milestone in the…
Read More » -
RIXOS MAKES ITS GRAND ENTRANCE INTO SAUDI ARABIA WITH THE OPENING OF RIXOS OBHUR JEDDAH
In a landmark moment for the Kingdom’s hospitality sector, Rixos Hotels announces the official opening of Rixos Obhur Jeddah, Saudi Arabia’s…
Read More » -
Lilly’s oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results
The investigational once-daily pill lowered A1C by an average of 1.3% to 1.6% across doses, with improvements seen as early…
Read More »